Association of the Gelatinase B/Metalloproteinase 9 (MMP-9) Gene Haplotype in Systemic Lupus Erythematosus (SLE) in the Pediatric Egyptian Population
Open Access
Abstract
Permanent systemic inflammation is a defining feature of systemic lupus erythematosus (SLE), which affects multiple organs. Gelatinase B/matrix metalloproteinase-9 (MMP-9) is an essential protease investigated in inflammation that has been linked to SLE. The study’s objective was to investigate the relationship between the rs3918249 T/C and rs17576 A/G SNPs in the MMP-9 gene with SLE. The study was conducted with 100 SLE cases and 100 age/sex-matched healthy individuals. TaqManTM SNP was used for genotyping by real time PCR on the Artus Rotor-Gene Qiagen equipment. Haplotypes (TG: OR = 0.226, 95% CI = 0.119–0.429) and (CA: OR = 0.36, 95% CI = 0.2206–0.631), both with a p-value < 0.001 were substantially linked to a lower incidence of SLE. Conversely, the risk of SLE was not associated with the individual SNPs studied. The haplotype analysis was more significant than the SNP analysis and may correlate with the decreased risk of SLE in children and adolescents in Egypt.Keywords
This publication has 38 references indexed in Scilit:
- Hematological Disorders in Patients with Systemic Lupus ErythematosusThe Open Rheumatology Journal, 2013
- Single nucleotide polymorphism in the MMP-9 gene is associated with susceptibility to develop multiple sclerosis in an Italian case-control studyJournal of Neuroimmunology, 2010
- Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse modelsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2010
- Matrix metalloproteinases as modulators of inflammationSeminars in Cell & Developmental Biology, 2008
- Regulation of matrix metalloproteinase gene expressionJournal of Cellular Physiology, 2006
- Circulating Total and Active Metalloproteinase‐9 and Tissue Inhibitor of Metalloproteinases‐1 in Patients with Systemic Lupus ErythomatosusMediators of Inflammation, 2006
- Careful attention to blood sampling as a preanalytical determinant of circulating matrix metalloproteinase 9 to avoid misinterpretations: Comment on the article by Ainiala et alArthritis & Rheumatism, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalitiesArthritis & Rheumatism, 2004
- Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosusClinical and Experimental Immunology, 2002